Maisa Yoshimoto

3.4k total citations
53 papers, 2.5k citations indexed

About

Maisa Yoshimoto is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Maisa Yoshimoto has authored 53 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 21 papers in Pulmonary and Respiratory Medicine and 16 papers in Genetics. Recurrent topics in Maisa Yoshimoto's work include Prostate Cancer Treatment and Research (18 papers), Cancer Genomics and Diagnostics (9 papers) and Genomic variations and chromosomal abnormalities (9 papers). Maisa Yoshimoto is often cited by papers focused on Prostate Cancer Treatment and Research (18 papers), Cancer Genomics and Diagnostics (9 papers) and Genomic variations and chromosomal abnormalities (9 papers). Maisa Yoshimoto collaborates with scholars based in Canada, Brazil and United States. Maisa Yoshimoto's co-authors include Jeremy A. Squire, Maria Zieleńska, Susan Chilton‐MacNeill, Anthony M. Joshua, Isabela Werneck da Cunha, Jane Bayani, Renata A. Coudry, Fernando Augusto Soares, F.P. Fonseca and Andrew Evans and has published in prestigious journals such as Journal of Clinical Oncology, ACS Nano and PLoS ONE.

In The Last Decade

Maisa Yoshimoto

52 papers receiving 2.5k citations

Peers

Maisa Yoshimoto
Comparison fields: 5 of 102
  • Molecular Biology 1.5k
  • Pulmonary and Respiratory Medicine 1.4k
  • Cancer Research 967
  • Oncology 455
  • Genetics 254
Bungo Furusato United States
Sunita R. Setlur United States
Arnulfo Mendoza United States
Laura Boldrini Italy
Shinji Takeuchi Japan
Yuichi Ishikawa Japan
Shi‐Ming Tu United States
Douglas I. Lin United States
Kimberly Straley United States
Ergin Kilic Germany
Bungo Furusato United States View profile →
Citations per field, relative to Maisa Yoshimoto
Maisa Yoshimoto · 1×
Citations per year, relative to Maisa Yoshimoto
Maisa Yoshimoto · 1×

Countries citing papers authored by Maisa Yoshimoto

Since Specialization
Citations

This map shows the geographic impact of Maisa Yoshimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maisa Yoshimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maisa Yoshimoto more than expected).

Fields of papers citing papers by Maisa Yoshimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maisa Yoshimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maisa Yoshimoto. The network helps show where Maisa Yoshimoto may publish in the future.

Co-authorship network of co-authors of Maisa Yoshimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Maisa Yoshimoto. A scholar is included among the top collaborators of Maisa Yoshimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maisa Yoshimoto. Maisa Yoshimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sections Laboratory Investigation Maisa Yoshimoto, Olga Ludkovski et al. 14
2 Copy number alterations of c‐MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy Cancer Gaetano Zafarana, Adrian Ishkanian et al. 92
3 Detection ofERGgene rearrangements andPTENdeletions in unsuspected prostate cancer of the transition zone Cancer Biology & Therapy Shuhong Liu, Maisa Yoshimoto et al. 30
4 Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma Cancer Genetics Georges Maire, Jeff W. Martin et al. 110
5 PTEN deletion and heme oxygenase‐1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome The Journal of Pathology Jie Su, Dingzhang Xiao et al. 57
6 Topographical analysis of telomere length and correlation with genomic instability in whole mount prostatectomies The Prostate Anthony M. Joshua, Erica Shen et al. 19
7 Cytogenetic molecular delineation of a terminal 18q deletion suggesting neo-telomere formation European Journal of Medical Genetics Leslie Domenici Kulikowski, Maisa Yoshimoto et al. 3
8 Analysis of Segmental Duplications, Mouse Genome Synteny and Recurrent Cancer-Associated Amplicons in Human Chromosome 6p21–p12 Cytogenetic and Genome Research Jeff W. Martin, Maisa Yoshimoto et al. 10
9 Recurrent RECQL4 Imbalance and Increased Gene Expression Levels Are Associated with Structural Chromosomal Instability in Sporadic Osteosarcoma Neoplasia Georges Maire, Maisa Yoshimoto et al. 46
10 Detailed cytogenetic and array analysis of pediatric primitive sarcomas reveals a recurrent CIC–DUX4 fusion gene event Cancer Genetics and Cytogenetics Maisa Yoshimoto, Cassandra Graham et al. 74
11 Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome Modern Pathology Maisa Yoshimoto, Anthony M. Joshua et al. 216
12 MP-17.17: FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome Urology Maisa Yoshimoto, Isabela Werneck da Cunha et al. 4
13 Expression of major vault protein gene in osteosarcoma patients Journal of Orthopaedic Research® Sílvia Regina Caminada de Toledo, Maisa Yoshimoto et al. 11
14 Hydrocephaly, penoscrotal transposition, and digital anomalies associated with de novo pseudodicentric rearranged chromosome 13 characterized by classical cytogenetic methods and mBAND analysis American Journal of Medical Genetics Part A Denise Maria Christofolini, Maisa Yoshimoto et al. 8
15 The use of whole genome amplification to study chromosomal changes in prostate cancer: insights into genome-wide signature of preneoplasia associated with cancer progression BMC Genomics Simon Hughes, Maisa Yoshimoto et al. 19
16 Establishment in Severe Combined Immunodeficiency Mice of Subrenal Capsule Xenografts and Transplantable Tumor Lines from a Variety of Primary Human Lung Cancers: Potential Models for Studying Tumor Progression–Related Changes Clinical Cancer Research Jean‐Claude Cutz, Jun Guan et al. 75
17 Three-Color FISH Analysis of TMPRSS2/ERG Fusions in Prostate Cancer Indicates That Genomic Microdeletion of Chromosome 21 Is Associated with Rearrangement Neoplasia Maisa Yoshimoto, Anthony M. Joshua et al. 140
18 Comparative genomic hybridization analysis of pediatric adamantinomatous craniopharyngiomas and a review of the literature Journal of Neurosurgery Pediatrics Maisa Yoshimoto, Sílvia Regina Caminada de Toledo et al. 17
19 Myelodysplastic syndrome in childhood: report of two cases with deletion of chromosome 4 and the Philadelphia chromosome Leukemia Research Maria Lúcia de Martino Lee, Maisa Yoshimoto et al. 6
20 MYCN Gene Amplification American Journal Of Pathology Maisa Yoshimoto, Sílvia Regina Caminada de Toledo et al. 27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026